News

Displaying 121 - 140 of 786

Registration opens for European Drugs Winter and Summer Schools 2022

The EMCDDA and the University Institute of Lisbon (ISCTE-IUL) are pleased to open registration today for two upcoming joint events in 2022: the European Drugs Winter School (EDWS) and the European Drugs...

EU4MD networking photo

News from EU4Monitoring Drugs, an EMCDDA technical cooperation project

This content was published in the EU4MD update released on 30.09.2021. This update also presents a section on partnerships, announcements, studies, upcoming events, and a research corner. Focus on: Methamphetamine from Afghanistan...

Picture of crystal methamphetamine

Methamphetamine from Afghanistan: ‘signals indicate that Europe should be better prepared’, says new EMCDDA report

This report was prepared before recent developments in Afghanistan and before the withdrawal of US military and other NATO allies from the country. The findings of this report are preliminary and will...

fragments of tiles in wall

Green light for two-year work programme on bilateral cooperation with Georgia

A two-year work programme on bilateral cooperation with Georgia was agreed upon today at the first advisory committee meeting of the EMCDDA4Georgia project, hosted virtually by the agency. Launched on 3 May...

picture of someone in bright red running shoes climbing stairs

Six steps to improve the quality of drug services and systems — EMCDDA launches new practical manual for decision-makers

Six steps to help improve the quality of drug services and systems in Europe are presented today in a new manual from the EU drugs agency (EMCDDA). Entitled Implementing quality standards for...

photo of jorge sampaio former president of portugal

In memoriam — His Excellency Dr Jorge Sampaio

It was with great sadness that the EMCDDA learned today of the passing of His Excellency Dr Jorge Sampaio, former President of the Portuguese Republic. Dr Jorge Sampaio was a highly-esteemed friend...

close-up of synthetic cannabinoid

New report highlights public health and social risks posed by synthetic cannabinoids in Europe

Synthetic cannabinoids come under the spotlight today in a new report released by the EU drugs agency (EMCDDA). Widely available across Europe and highly potent, these substances are placing some users at...

speakers at a conference

EMCDDA expert meeting on digital health innovation

Recent EMCDDA studies on the impact of COVID-19 containment measures on drug services in Europe highlighted the rapid and widespread adoption of telemedicine and online communication. In some countries, core drug treatment...

3 wooden dice with letters f a q in black font

International Overdose Awareness Day: EMCDDA answers key questions on drug-related deaths

How many people die every year in Europe from a drug-related death? Are women and men affected equally? What substances are involved in these fatalities? These are some of the questions answered...

hepatitis world day theme 2021: hep can't wait

EMCDDA launches new resources to help European countries beat viral hepatitis

On World Hepatitis Day, the EU drugs agency (EMCDDA) is launching a new set of resources to help European countries meet health targets to eliminate viral hepatitis. The resources, presented in an...

close up of dried cannabis buds

France: Parliamentary Committee reports on cannabis regulation

In May 2021, a multidisciplinary committee established by the French Parliament published three reports on cannabis regulation. The reports, totalling 450 pages, address the regulation and impact of three types of cannabis...

picture of Tomáš Zábranský

In memoriam — Tomáš Zábranský

It was with great sadness that the EMCDDA learned this week of the passing of its long-term friend and colleague Tomáš Zábranský MD, PhD. Dr Zábranský was a highly-esteemed Czech epidemiologist, who...

image of long brown tables and stools in classroom

EMCDDA Best practice portal update (3/2021)

Contingency Management – evidence continues to build-up, time to start talking about implementation? According to the just published EMCDDA European Drug Report cocaine is the second most commonly used illicit drug in...

EU4MD networking photo

News from EU4Monitoring Drugs, an EMCDDA technical cooperation project

This content was published in the EU4MD update released on 30.06.2021. This update also presents a section on partnerships, annoucements, studies, upcoming events, and a research corner. Focus on: European Drug Report...

Picture shows outside of prision with razor wire.

New EMCDDA report underlines need to scale up drug services in prisons

Current insights and future challenges on drugs and prison in Europe are explored today in a major new study published by the EU drugs agency (EMCDDA)(1). Released on the eve of International...

Council approves EU Drugs Action Plan 2021–2025

The Council of the EU (Foreign Affairs) approved on 21 June the EU Drugs Action Plan for 2021–2025. The new plan presents the concrete actions needed to achieve the priorities of the...

hand holding light bulb on a white wooden background

A year in review: General Report of Activities 2020 published today

Resilience, agility and innovation are among the recurring themes in the latest EMCDDA General Report of Activities, released today. The annual publication — presenting key achievements and governance — relates how the...

image of part of the european drug report 2021

European drug market proves resilient to COVID-19 disruption

Today, the EU drugs agency (EMCDDA) publishes its European Drug Report 2021: Trends and Developments, the latest annual review of the drug situation in Europe (1). Based on data from 29 countries...

yellow and white pills on a light grey background

New report highlights public health risks and increasing availability of ‘designer benzodiazepines’ in Europe

New benzodiazepines, which are not controlled by international drug laws, come under the spotlight today in a new report released by the EU drugs agency (EMCDDA) (1). Often marketed as ‘designer benzodiazepines’...

Speech delivered by Laura d’Arrigo, Chair of the EMCDDA Management Board, on the launch of the European Drug Report 2021

Since early 2020, the COVID-19 pandemic has had a dramatic impact on the way in which we live. Countries in Europe, and around the world, have had to introduce unprecedented measures to...